In contrast, JAK2 mutations, which did not achieve significance, trended in both younger (40s and 50s) and older age groups (70s) ( Fig. 1c ).
← all excerpts
Age-related mutations associated with clonal hematopoietic expansion and malignancies.
1
—
—